ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

GOVX GeoVax Labs Inc

1.61
0.19 (13.38%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
GeoVax Labs Inc GOVX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.19 13.38% 1.61 13:00:05
개장가 저가 고가 종가 전일 종가
1.42 1.42 1.70 1.61 1.42
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
05/04/202401:30GLOBEGeoVax Presents Data on GEO-CM04S1, a Next Generation..
28/03/202422:00GLOBEGeoVax to Present Data on GEO-CM04S1, a Next Generation..
12/03/202422:00GLOBEGeoVax to Present at the 36th Annual Roth Conference
12/03/202405:13EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
11/03/202413:15EDGAR2Form EFFECT - Notice of Effectiveness
06/03/202423:00GLOBEGeoVax Achieves Milestone in Transition to Commercially..
02/03/202406:08EDGAR2Form S-3 - Registration statement under Securities Act of..
01/03/202406:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/03/202406:00GLOBEGeoVax Reports 2023 Year-End Financial Results and Provides..
23/02/202406:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202423:00GLOBEGeoVax to Report 2023 Financial Results and Provide..
19/02/202423:00GLOBEGeoVax to Present at the 2024 BIO CEO & Investor Conference
17/02/202406:01EDGAR2Form 8-K - Current report
15/02/202405:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/02/202423:00GLOBEGeoVax Announces Multiple Patent Issuances and Allowances
08/02/202406:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202423:00GLOBEGeoVax Reports Positive Interim Data From Phase 2 Clinical..
01/02/202403:13EDGAR2Form 8-K - Current report
29/01/202423:00GLOBEGeoVax Announces 1-for-15 Reverse Stock Split to Regain..
17/01/202406:03EDGAR2Form 8-K - Current report
13/01/202406:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/01/202423:00GLOBEGeoVax Appoints Dr. Marc Pipas as Executive Medical..
04/01/202423:00GLOBEGeoVax Announces Gedeptin® Patient Enrollment Closure for..
03/01/202423:00GLOBEGeoVax Announces Issuance of Malaria Vaccine Patent
03/01/202406:10EDGAR2Form S-1 - General form for registration of securities under..
27/12/202323:00GLOBEGeoVax to Present at Biotech Showcase During J.P. Morgan..
27/12/202305:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202323:00GLOBEGeoVax Expands Rights Under NIH COVID-19 License to Include..
09/12/202306:02EDGAR2Form 8-K - Current report
04/12/202322:00EDGAR2Form 8-K - Current report
01/12/202306:30GLOBEGeoVax Hemorrhagic Fever Vaccine Data Presented at World..
29/11/202323:00GLOBEGeoVax to Participate in Upcoming December Investor Events
28/11/202323:00GLOBEGeoVax COVID-19 Vaccine Clinical Data Presented at World..
28/11/202306:06EDGAR2Form DEF 14A - Other definitive proxy statements
18/11/202306:27EDGAR2Form PRE 14A - Other preliminary proxy statements
14/11/202323:00GLOBEProgress on GeoVax’s Universal Coronavirus Vaccine..
10/11/202302:40EDGAR2Form 8-K - Current report
09/11/202306:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/11/202306:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/11/202306:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/11/202306:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:00GLOBEGeoVax Reports Third Quarter 2023 Financial Results and..
31/10/202322:00GLOBEGeoVax to Report Third Quarter 2023 Financial Results and..
30/10/202322:00GLOBEGeoVax Commences Site Expansion for Phase 2 Trial of..
25/10/202322:00GLOBEGeoVax to Participate in Upcoming November Investor and..
24/10/202322:00GLOBEGeoVax Update: Clinical and Operational Progress Toward..
09/10/202322:00GLOBEGeoVax Receives Notice of Allowance for Marburg Vaccine..
05/10/202322:00GLOBEGeoVax Receives Notice of Allowance for HIV Vaccine Patent
28/09/202305:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/09/202322:00GLOBEGeoVax to Participate in Upcoming October Investor and..

최근 히스토리

Delayed Upgrade Clock